Renown Health inks data-tracking deal with BioIntelliSense | Serving Northern Nevada
BioIntelliSense
BioIntelliSense uses Rhapsody for COVID-19 screening, monitoring & trials | Rhapsody
BioIntelliSense
BioIntelliSense Announces FDA Clearance of the BioSticker™, the First Single-Use Medical Device Enabling 30 Days of Continuous Vital Signs Monitoring
BioIntelliSense
Renown Health to Deploy BioIntelliSense's RPM Device
BioIntelliSense Announces FDA Clearance of the BioSticker™, the First Single-Use Medical Device Enabling 30 Days of Continuous
BioIntelliSense rakes in $45M for remote monitoring data platform, symptom-tracking stickers | Fierce Biotech
Mubadala Health Partners with BioIntelliSense
New BioSticker Medical Device is for Single-Use and Can Collect Data up to 30 Days
BioIntelliSense
BioIntelliSense Partnership, Remote Patient Monitoring | Anelto U.S.A.
BioIntelliSense
Remote Monitoring for Oncology Care • Jasper Health
BioIntelliSense
COVID-19-Monitoring Coin-Sized Wearable Unveiled | IE
BioIntelliSense
BioIntelliSense
Philips Partners with BioIntelliSense - News | Philips
BioIntelliSense
UCHealth, CU and Denver based company partner on new bio-sticker
BioIntelliSense debuts rechargeable version of its wearable vital sign tracker | Fierce Biotech
Golden-based BioIntelliSense gets $45M in financing to scale vital-monitoring sticker - Denver Business Journal
